推荐产品
质量水平
形式
solid
浓度
18-20% Fe (T)
痕量阴离子
chloride (Cl-): ≤500 mg/kg
痕量阳离子
Ca: ≤100 mg/kg
Cd: ≤50 mg/kg
Co: ≤50 mg/kg
Cu: ≤50 mg/kg
K: ≤500 mg/kg
Na: ≤200 mg/kg
Ni: ≤100 mg/kg
Pb: ≤50 mg/kg
Zn: ≤50 mg/kg
SMILES字符串
OC12CC(=O)O[Fe](OC(=O)C1)OC2=O
InChI
1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
InChI key
NPFOYSMITVOQOS-UHFFFAOYSA-K
正在寻找类似产品? 访问 产品对比指南
应用
柠檬酸三钠一水合物铁 (III) 可用作在制备灌注溶液期间使用的其中一种组合物的铁源。
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
Tatsuya Fukushima et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(42), 16829-16834 (2012-10-03)
Citrate is a common biomolecule that chelates Fe(III). Many bacteria and plants use ferric citrate to fulfill their nutritional requirement for iron. Only the Escherichia coli ferric citrate outer-membrane transport protein FecA has been characterized; little is known about other
Marcus J Edwards et al.
Structure (London, England : 1993), 20(7), 1275-1284 (2012-06-12)
Members of the genus Shewanella translocate deca- or undeca-heme cytochromes to the external cell surface thus enabling respiration using extracellular minerals and polynuclear Fe(III) chelates. The high resolution structure of the first undeca-heme outer membrane cytochrome, UndA, reveals a crossed
Miriam A Rosenbaum et al.
PloS one, 7(2), e30827-e30827 (2012-02-10)
Shewanella oneidensis is a target of extensive research in the fields of bioelectrochemical systems and bioremediation because of its versatile metabolic capabilities, especially with regard to respiration with extracellular electron acceptors. The physiological activity of S. oneidensis to respire at
Guus A M Kortman et al.
PloS one, 7(1), e29968-e29968 (2012-01-25)
Recent trials have questioned the safety of untargeted oral iron supplementation in developing regions. Excess of luminal iron could select for enteric pathogens at the expense of beneficial commensals in the human gut microflora, thereby increasing the incidence of infectious
Akio Iida et al.
American journal of nephrology, 37(4), 346-358 (2013-04-04)
Ferric citrate hydrate (JTT-751) is being developed as a treatment for hyperphosphatemia in chronic kidney disease patients, and shows serum phosphorus-reducing effects on hyperphosphatemia in hemodialysis patients. We examined whether JTT-751 could reduce phosphorus absorption in normal rats and prevent
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门